Literature DB >> 7546618

Colorectal adenoma progression and genetic change: is there a link?

J R Jass1.   

Abstract

Focal neoplastic change occurs frequently within the colorectum. Yet, of the several hundreds of microadenomas that are likely to be present within an individual colorectum, only one or two will develop into a clinically diagnosable adenoma. In turn, only a fraction of adenomas will progress to malignancy. The risk that a particular microadenoma will end its natural history as a carcinoma varies according to clinical context. The risk is very low in familial adenomatous polyposis (FAP), but relatively high in hereditary non-polyposis colorectal cancer (HNPCC). This variation is governed by the timing and ordering of the underlying mutational events. In FAP, inactivation of the wild-type APC gene occurs early, whereas K-ras mutations are late events. The converse appears to apply in the case of sporadic adenomas. In flat adenomas, which are known to be relatively aggressive, K-ras mutations may not occur at all. In HNPCC, mutational events are accelerated as a result of defective DNA mismatch repair. The evolution of colorectal adenoma occurs through a variety of quite distinct genetic pathways.

Entities:  

Mesh:

Year:  1995        PMID: 7546618     DOI: 10.3109/07853899509002581

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  6 in total

1.  Utility of computed tomographic colonography in surveillance for hereditary nonpolyposis colorectal cancer syndrome.

Authors:  Laura Renkonen-Sinisalo; Arto Kivisaari; Leena Kivisaari; Seppo Sarna; Heikki J Järvinen
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

2.  Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas.

Authors:  M Anti; A Armuzzi; S Morini; E Iascone; G Pignataro; C Coco; R Lorenzetti; M Paolucci; M Covino; A Gasbarrini; F Vecchio; G Gasbarrini
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 3.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

Review 4.  Cancer in Jews: introduction and overview.

Authors:  Henry T Lynch; Wendy S Rubinstein; Gershon Y Locker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

5.  Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer.

Authors:  S E Green; P Chapman; J Burn; A D Burt; M Bennett; D R Appleton; J S Varma; J C Mathers
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

6.  Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients.

Authors:  A S Soliman; M L Bondy; S A El-Badawy; N Mokhtar; S Eissa; S Bayoumy; I A Seifeldin; P S Houlihan; J R Lukish; T Watanabe; A O Chan; D Zhu; C I Amos; B Levin; S R Hamilton
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.